期刊文献+

侧脑室注射UrocortinⅢ对大鼠不同脑区Fos表达的影响 被引量:5

Influence of intracerebroventricular injection of urocortin Ⅲ on Fos expression in rat brain areas
暂未订购
导出
摘要 目的 :确定脑室注射UrocortinⅢ后被激活细胞群的分布 ,并判断这些细胞群的分布与其受体 (促肾上腺皮质激素释放因子 2型受体 ,CRF2R)的分布吻合程度 .方法 :应用免疫组织化学方法观察侧脑室注射UrocortinⅢ对大鼠不同脑区Fos表达的影响 .结果 :脑室给予UrocortinⅢ引起许多脑区Fos表达明显增多 ,包括隔外侧核、终纹床核、下丘脑室旁核、弓状核、杏仁中央核、臂旁核、孤束核和最后区 .结论 :侧脑室给予UrocortinⅢ激活了与味觉和摄食调控相关的细胞群以及与应激相关的细胞群 。 AIM: To identify cell groups responsive to central urocortin Ⅲ administration and to evaluate the extent to which these cell groups may conform to the sites of CRF2R (corticotropin releasing factor 2 receptor ) expression. METHODS: The influence of intracerebroventricular injection of urocortin Ⅲ on Fos expression in rat brain areas was observed with immunohistochemical staining technique. RESULTS: Urocortin Ⅲ induced Fos expression in several brain areas, including lateral septal nucleus (LS), the bed nucleus of the stria terminalis (BST), paraventricular hypothalamus nucleus (PVN), arcuate hypothalamic nucleus (ARC), the central nucleus of the amygdala (CeA), parabrachial nucleus (PBN), nucleus of the solitary tract(NTS) and area postrema (AP). CONCLUSION: Intracerebroventricular injection of urocortin Ⅲ activates cell groups related with gustation, feeding and stress, the distribution of which partially overlaps with the sites of CRF2R expression.
出处 《第四军医大学学报》 CAS 北大核心 2004年第11期969-972,共4页 Journal of the Fourth Military Medical University
基金 国家自然科学基金 (30 2 70 4 54) 陕西省科技发展计划项目(2 0 0 2K1 0 G7 0 1 )
关键词 UrocortinⅢ 脑室注射 FOS表达 urocortinⅢ intracerebroventricular injection Fos expression
  • 相关文献

参考文献10

  • 1Lewis K, Li C, Perrin MH, et al. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor [J]. Proc Natl Acad Sci USA, 2001; 98(13): 7570-7575.
  • 2Wchenko PE, Vale WW. Urocortin III-immunoreactive projections in rat brain: Partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression[J]. J Neurosci, 2002; 22(3): 991-1001.
  • 3Li C, Chen P, Vaughan J, et al. UrocortinIII is expressed in pancreatic beta-cells and stimulates insulin and glucagons secretion [J]. Endocrinology, 2003; 144(7): 3216-3224.
  • 4Brar BK, Jonassen AK, Egorina EM, et al. Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: An essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart[J]. Endocrinology, 2004;145(1):24-35.
  • 5Martinez V, Wang L, Rivier JE, et al. Differential actions of peripheral corticotropin-releasing factor (CRF), urocortin II, and urocortin III on gastric emptying and colonic transit in mice: Role of CRF receptor subtypes 1 and 2[J]. J Pharmacol Exp Ther, 2002; 301(2): 611-617.
  • 6Valdez GR, Zorrilla EP, Rivier J, et al. Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist[J]. Brain Res, 2003; 980(2): 206-212.
  • 7Million M, Maillot C, Saunders P, et al. Human urocortin II, a new CRF-related peptide, displays selective CRF (2)-mediated action on gastric transit in rats [J]. Am J Physiol Gastrointest Liver Physiol, 2002; 282(1): G34-G40.
  • 8Cullen MJ, Ling N, Foster AC, et al. Urocortin, corticotropin-releasing factor -2 receptors and energy balance [J]. Endocrinology, 2001; 142(3):992-999.
  • 9Million M, Saunders P, Rivier J, et al. Compound 338-86-15, a novel peptide CRF-R2 antagonist, selectively blocks CRF and stress-induced delayed gastric emptying in rats. [J]. Soc Neurosci Abstr, 2001; 27: 817-839.
  • 10Reul JM, Holsboer F. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression [J]. Curr Opin Pharmacol, 2002; 2(1): 23-33.

同被引文献43

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部